Skip to content
GenoLensGenoLens

IFT43

Chr 14q24.3

intraflagellar transport 43

Aliases:
FLJ32173, MGC16028
MANE:
ENST00000314067.11

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Rare multisystem ciliopathy disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Renal ciliopathies

    BIALLELIC, autosomal or pseudoautosomal
  • Skeletal ciliopathies

    BIALLELIC, autosomal or pseudoautosomal
  • Skeletal dysplasia

    BIALLELIC, autosomal or pseudoautosomal
  • Thoracic dystrophies

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal

+6 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • cranioectodermal dysplasia

    0.70
  • cranioectodermal dysplasia 3

    0.68
  • short-rib thoracic dysplasia 18 with polydactyly

    0.66
  • retinitis pigmentosa

    0.50
  • short rib dysplasia

    0.46
  • retinitis pigmentosa 81

    0.42
  • short rib-polydactyly syndrome

    0.33
  • smoking initiation

    0.26
  • ovarian dysfunction

    0.26
  • migraine disorder

    0.25

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Intraflagellar transport protein 43 homolog

As a component of IFT complex A (IFT-A), a complex required for retrograde ciliary transport and entry into cilia of G protein-coupled receptors (GPCRs), it is involved in ciliogenesis (PubMed:28400947, PubMed:28973684). Involved in retrograde ciliary transport along microtubules from the ciliary tip to the base (PubMed:21378380)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.